Activated VEGF Receptor Shed Into the Vitreous in Eyes With Wet AMD: A New Class of Biomarkers in the Vitreous With Potential for Predicting the Treatment Timing and Monitoring Response

類似資料

• Anti-VEGF Treatment Strategies for Wet AMD
  著者:: Kovach, Jaclyn L., 等
  出版事項: (2012)
• Short-term outcomes of switching anti-VEGF agents in eyes with treatment-resistant wet AMD
  著者:: Batioglu, Figen, 等
  出版事項: (2015)
• Mass spectrometry-based characterization of the vitreous phosphoproteome
  著者:: Tamburro, Davide, 等
  出版事項: (2010)
• Sequential in-office vitreous aspirates demonstrate vitreous matrix metalloproteinase 9 levels correlate with the amount of subretinal fluid in eyes with wet age-related macular degeneration
  著者:: Ecker, Stephanie M., 等
  出版事項: (2012)
• Preclinical aspects of anti-VEGF agents for the treatment of wet AMD: ranibizumab and bevacizumab
  著者:: Meyer, C H, 等
  出版事項: (2011)